G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan · Delayed Price · Currency is TWD 49.05
-0.05 (-0.10%)
Oct 31, 2025, 1:30 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 2.89 billion as of October 31, 2025. Its market cap has decreased by -4.60% in one year.
Market Cap
2.89B
Enterprise Value
2.44B
Revenue
294.26M
Ranking
n/a
PE Ratio
23.23
Stock Price
49.05
Market Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has increased from 2.62B to 2.89B, an increase of 10.50%. That is a compound annual growth rate of 0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 2.89B | -13.34% |
| Dec 31, 2024 | 3.34B | -2.92% |
| Dec 29, 2023 | 3.44B | 15.73% |
| Dec 30, 2022 | 2.97B | 90.71% |
| Dec 30, 2021 | 1.56B | -19.66% |
| Dec 31, 2020 | 1.94B | -3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |